Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Indofarma Tbk. (INAF) vs Tripar Multivision Plus Tbk. (RAAM) Price & Performance

Indofarma Tbk.Trade
Tripar Multivision Plus Tbk.Trade

Price performance (Past 24H)

Key statistics

Indofarma Tbk. vs Tripar Multivision Plus Tbk. — how do they compare? Indofarma Tbk. trades at Rp126 (market cap 390.51B), while Tripar Multivision Plus Tbk. trades at Rp176 (market cap 1.23T, 1.26M 24h volume). The key difference: Tripar Multivision Plus Tbk. is far larger — about 3.1× Indofarma Tbk.'s market cap. Which is the better fit depends on your goals.

INAFRAAM
Market Cap
390.51B1.23T
Volume
1.26M
Lot
12.56K
Turnover
222.66M
Average Price
177.28
Value
222.66M
Indicative Equilibrium Price
176
Indicative Equilibrium Volume
1.39K

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

INAF
View details
RAAM
View details

About Indofarma Tbk.

PT Indonesia Farma Tbk, known as PT Indofarma (Persero) Tbk (the Company) was established based on Deed No. 1 dated January 2, 1996 as amended by Deed No. 134 dated January 26, 1996 both of Notary Sutjipto, SH. PT. Indofarma, Tbk began as medicine factory well known as "Pabrik Obat Manggarai". Then take over by Japan's Government from Nederland's Government on 1942. On 1950 the Indonesian Government acquisited the factory by Department of Health and functioned as center of pharmacy production for its department. On 1979 the name changed to be Department of Health Center of Pharmacy Production as non Profit institution as main assignment to produced medicine for public service. Then the Company changed the name as PT. Indonesia Farma Tbk, known as PT Indofarma (Persero) Tbk.

Read more on INAF

About Tripar Multivision Plus Tbk.

PT Tripar Multivision Plus Tbk (“the Company”) was establishedbased on Deed of Establishment of Limited Liability Company No. 17 dated 6 December 1990 drawn up before Adlan Yulizar, S.H., notary in Jakarta.

Read more on RAAM